Evolus reports positive trial results for Evolysse Sculpt dermal filler

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/13/2026

1. ORCL
2. ADBE
3. RH
4. SPY
5. CPRT
6. ACVA
7. SEDG
8. SPCX
9. TLT
10. PMTS

Go back to Evolus reports positive trial results for Evolysse Sculpt dermal filler
(NASDAQ: EOLS) Delayed: 7.84 -0.07 (0.88%)
Previous Close $7.91    52 Week High $ 
Open $8.01    52 Week Low $ 
Day High $8.15    P/E N/A 
Day Low $7.81    EPS $ 
Volume 586,591